• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » UC $250m tech innovation fund goes to NBA Kings owner Ranadivé

UC $250m tech innovation fund goes to NBA Kings owner Ranadivé

December 16, 2015 By Fink Densford

University of CaliforniaThe University of California said it will put the funds from its $250 million tech fund into the care of entrepreneur Vivek Ranadivé, who will lead and build a team to invest in innovations coming out of the UC system.

Ranadivé is the former CEO of multi-million dollar real-time computing company TIBCO and owner and chairman of the NBA’s Sacramento Kings.

“Vivek is a visionary who has transformed the way businesses operate across the world and developed his own innovations in Silicon Valley. Our shared vision for investing in UC innovation, our alignment of values and our investment beliefs solidified the relationship,” UC Chief Investment Officer Jagdeep Bachher said in a press release.

In September, UC approved the cross-disciplinary innovation investment spanning life sciences, tech, energy, agriculture and materials, according to a press release from the University.

“Our business plan for the UC innovation fund is designed for the next 100 years. Therefore, it’s important that we get this right with a great team and an independent structure, which is what we have accomplished by recruiting Vivek to lead the fund,” UC Board of Regents Committee on Investments chair Paul Wachter said in prepared remarks.

The fund, named UC Ventures, aims to generate “attractive, risk-adjusted returns by investing in commercial opportunities arising from the University of California,” according to a press release. No tuition or state funding will be used in the venture.

“It is a tremendous honor to partner with the University of California in this unique collaboration focused on investing in breakthrough technologies emerging from the world-class University of California system. As an entrepreneur, I look forward to supporting fellow entrepreneurs and growing innovative, value-driven enterprises with a mission to advance our society and make the world a better place,” Ranadivé said in a press release.

The UC Venture fund was originally created to be a stand-alone, independent investment vehicle looking at long-term opportunities. Along with its creation, UC said it put together an advisory board to provide advice and insight to the UC Ventures fund.

Filed Under: Business/Financial News Tagged With: University of California

In case you missed it

  • Wearable infusion device maker Bexson Biomedical appoints senior VP of drug delivery
  • PLx Pharma prices $63M offering
  • 5 reasons Medtronic’s CEO is optimistic about the future
  • Medtronic is changing a lot: Here’s what you need to know
  • N.J. appeals court tosses $83M pelvic mesh verdicts against J&J, Bard
  • Magenta Therapeutics rises on Street-beating Q4
  • Abbott COVID-19 serology test gains EUA
  • Asensus Surgical wins FDA nod for general surgery with Senhance robotic surgery system
  • Boston Scientific to acquire Lumenis surgical business for $1.07B
  • TransMedics jumps on Street-beating Q4 results
  • FDA clears Neurolief’s noninvasive neuromod tech to treat migraines
  • Could this hydrogel repair a broken heart?
  • Virta Health touts study of treatment preventing progression to Type 2 diabetes
  • Philips, DiA partner on AI-based applications for ultrasound
  • Cook Medical wins FDA breakthrough device designation for next-gen endovascular graft
  • FDA grants breakthrough nod to Anuncia’s cerebral spinal fluid treatment
  • Varian CEO Dow Wilson to retire after merger with Siemens Healthineers

RSS From Medical Design & Outsourcing

  • Pharma’s been slow to adopt Industry 4.0 — but that could change
    The pharma industry has been relatively slow to embrace concepts such as Industry 4.0, but COVID-19 is serving as a catalyst for sweeping changes within the industry. The philosophy has roots in a German framework that prioritizes digitization to drive manufacturing efficiency, promising that cyber-physical systems will usher in the next industrial revolution. The Industry… […]
  • Ambu single-use endoscope wins Frost & Sullivan innovation award
    Frost & Sullivan today announced that it awarded Ambu with a 2021 Global New Product Innovation Award. Ambu received the award for its single-use flexible endoscopes that are designed to make the devices safe, affordable and accessible. It has aView and aBox all-in-one video displays that eliminate the traditional video endoscopy tower size and expense to be… […]
  • Could this hydrogel repair a broken heart?
    European researchers have developed an injectable hydrogel that could help repair and prevent further heart muscle damage after a heart attack. The therapeutic effect of multiple injections of this hydrogel into the cardiac tissue was assessed during the first preclinical study of its kind, demonstrating its efficacy for cardiac tissue remodeling following a heart attack,… […]
  • How EtO plants can avoid lawsuits, cope with stricter regulation
    If EtO industry actors take certain targeted steps now, they can minimize legal exposure, more efficiently manage litigation and be better situated for compliance once new federal regulations are established. Karen Cullinane, Goldberg Segalla The use of ethylene oxide (EtO) to sterilize medical devices came under renewed scrutiny after the Environmental Protection Agency concluded in… […]
  • FDA authorizes Q-Collar to help protect athletes’ brains
    The FDA announced today that it authorized the Q-Collar made by Q30 Sports Science for protecting the brain during sports activities. Q30 Sports Science’s Q-Collar is a C-shaped collar worn around the neck designed to apply compressive force to the neck and increase blood volume to help reduce movement of the brain within the cranial… […]
  • The top 7 medtech CEO quotes on COVID-19, one year later
    The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world… […]
  • Pfizer wins FDA nod to store COVID vaccine at normal freezer temps
    The FDA announced today that it is allowing undiluted, frozen vials of the Pfizer-BioNTech COVID-19 vaccine to be transported and stored for up to two weeks at conventional temperatures commonly found in pharmaceutical freezers. The decision should allow for wider distribution of the vaccine to sites that do not have ultra-low temperature freezers. Pfizer asked… […]
  • 8 drug delivery innovations you need to know
    The drug delivery space has seen plenty of innovation over the years, and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the… […]
  • Hoffer Plastics gains MedAccred certification again
    Injection molding company Hoffer Plastics (South Elgin, Ill.) announced that it has received the MedAccred re-certification from not-for-profit medtech audit provider MedAccred. MedAccred is a supply-chain oversight program of the Performance Review Institute. It conducts critical-process audits for its member OEMs to ensure their suppliers adhere to global regulations and requirements, and helps reduce the number… […]
  • UK passes post-Brexit medical device regulation
    The U.K. has enacted a new law governing medical devices and drugs, with a focus on patient safety. The Medicines and Medical Devices Act, introduced in July 2020, establishes the position of commissioner for patient safety to respond to public and patient complaints and concerns about drugs and medical devices. The law was necessitated by… […]
  • Integrated Polymer Solutions acquires IRP Group
    Integrated Polymer Solutions (“IPS”), a portfolio company of Arcline Investment Management, announced this week that it has acquired IRP Group. IRP designs and manufacturers elastomeric sealing components from its facilities in Southern California. Founded in 1999, the company is focused on the Class I and II medical device market as well as the aerospace &… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS